Meiragtx Holdings PLC - (MGTX) closed at $8.32 on November 18, 2026, down 1.7% from the previous close, on volume of 541,156 shares (30-day average 712,751).
Data as of November 18, 2026.
18-Nov-2026
MeiraGTx Announces Oral Presentation at ObesityWeek 2026
Globe Newswire (Mon, 16-Nov 7:00 AM ET)
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
Globe Newswire (Thu, 12-Nov 8:00 AM ET)
Globe Newswire (Tue, 27-Oct 8:00 AM ET)
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
Globe Newswire (Wed, 23-Sep 8:00 AM ET)
PRNewswire (Wed, 26-Aug 10:51 AM ET)
Market Chameleon (Tue, 7-Jul 3:50 AM ET)
Market Chameleon (Fri, 17-Apr 7:09 AM ET)
Market Chameleon (Thu, 26-Mar 4:35 AM ET)
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Meiragtx Holdings PLC - trades on the NASDAQ stock market under the symbol MGTX.
As of November 18, 2026, MGTX stock price declined to $8.32 with 541,156 million shares trading.
MGTX has a beta of 2.05, meaning it tends to be more sensitive to market movements. MGTX has a correlation of 0.19 to the broad based SPY ETF.
MGTX has a market cap of $813.12 million. This is considered a Small Cap stock.
Last quarter Meiragtx Holdings PLC - reported $5 million in Revenue and -$.53 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.06.
In the last 3 years, MGTX traded as high as $15.35 and as low as $3.85.
The top ETF exchange traded funds that MGTX belongs to (by Net Assets): IWM, FYC, IBB, IWO, VTWO.
MGTX has underperformed the market in the last year with a price return of +7.4% while the SPY ETF gained +11.8%. MGTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.1% and -11.7%, respectively, while the SPY returned -4.6% and -4.8%, respectively.
MGTX support price is $8.13 and resistance is $8.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MGTX shares will trade within this expected range on the day.